Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Sandini · SciRah

Researcher profile · Semantic Scholar

L. Sandini

Share profile

L. Sandini — researcher profile on SciRah

h-index: 16
Works: 25
Citations: 937

Most-cited papers

Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study.
K. Pentti, M. Tuppurainen, R. Honkanen, L. Sandini +3 more
2009Maturitas126 citations
Semantic Scholar
Effect of vitamin D3 and calcium on fracture risk in 65‐ to 71‐year‐old women: A population‐based 3‐year randomized, controlled trial—the OSTPRE‐FPS
Kari Salovaara, M. Tuppurainen, M. Kärkkäinen, T. Rikkonen +5 more
2010Journal of Bone and Mineral Research115 citations
Semantic Scholar
Comparison of Three Bone Ultrasounds for the Discrimination of Subjects With and Without Osteoporotic Fractures Among 7562 Elderly Women
M. Krieg, J. Cornuz, C. Ruffieux, L. Sandini +14 more
2003Journal of Bone and Mineral Research84 citations Open access
Semantic Scholar
Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65–71 years: a 3-year randomized population-based trial (OSTPRE-FPS)
Merja U. M. Kärkkäinen, M. Tuppurainen, Kari Salovaara, L. Sandini +6 more
2010Osteoporosis International82 citations
Semantic Scholar
Intravenous Pamidronate as Treatment for Osteoporosis after Heart Transplantation: A Prospective Study
M. Krieg, C. Seydoux, L. Sandini, J. Goy +3 more
2001Osteoporosis International77 citations
Semantic Scholar
Factors affecting bone loss around menopause in women without HRT: a prospective study.
J. Sirola, H. Kröger, R. Honkanen, J. Jurvelin +3 more
2003Maturitas76 citations
Semantic Scholar
Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65-71 years? A 3-year randomized population-based trial (OSTPRE-FPS).
M. Kärkkäinen, M. Tuppurainen, Kari Salovaara, L. Sandini +6 more
2010Maturitas59 citations
Semantic Scholar
Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study.
K. Pentti, M. Tuppurainen, R. Honkanen, L. Sandini +3 more
2009European Journal of Endocrinology57 citations Open access
Semantic Scholar
Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
L. Sandini, J. Arokoski, J. Jurvelin, H. Kröger
2005Journal of Rheumatology43 citations
Semantic Scholar
Risk factors associated with peri- and postmenopausal bone loss: does HRT prevent weight loss-related bone loss?
J. Sirola, H. Kröger, R. Honkanen, L. Sandini +3 more
2003Osteoporosis International41 citations
Semantic Scholar
Protective and Risk Factors for Allergic Diseases in High-Risk Children at the Ages of Two and Five Years
Urpu Sandini, A. Kukkonen, T. Poussa, L. Sandini +2 more
2011International Archives of Allergy and Immunology39 citations
Semantic Scholar
Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE)
L. Sandini, K. Pentti, M. Tuppurainen, H. Kröger +1 more
2008Menopause36 citations
Semantic Scholar
Smoking May Impair the Bone Protective Effects of Nutritional Calcium: A Population‐Based Approach
J. Sirola, H. Kröger, R. Honkanen, L. Sandini +3 more
2003Journal of Bone and Mineral Research31 citations
Semantic Scholar
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study.
K. Pentti, R. Honkanen, M. Tuppurainen, L. Sandini +2 more
2006European Journal of Endocrinology25 citations Open access
Semantic Scholar
Intravenous ibandronate in men with osteoporosis: An open pilot study over 2 years
O. Lamy, L. Sandini, I. Pache, S. Fatio +2 more
2003Journal of Endocrinological Investigation23 citations
Semantic Scholar
Interaction of Nutritional Calcium and HRT in Prevention of Postmenopausal Bone Loss: A Prospective Study
J. Sirola, H. Kröger, L. Sandini, M. Tuppurainen +3 more
2003Calcified Tissue International17 citations
Semantic Scholar
Factors associated with the use of hormone replacement therapy among older women.
J. Cornuz, M. Krieg, L. Sandini, C. Ruffieux +14 more
2003Age and Ageing8 citations Open access
Semantic Scholar
Do we need lyso Gb3 measurement in monitoring Fabry disease?
I. Kantola, A. Annala, T. M. Helioe, Aki J. Hietaharju +13 more
2026Molecular Genetics and Metabolism0 citations
Semantic Scholar
PQ interval, QRS duration and QTc interval increased in Fabry disease patients treated by enzyme replacement therapy both for 10 and 15 years
I. Kantola, A. Annala, A. Ekstrand, Tiina Helio +14 more
20200 citations
Semantic Scholar
Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 years
I. Kantola, A. Annala, A. Ekstrand, T. Heliö +17 more
2019Molecular Genetics and Metabolism0 citations
Semantic Scholar
Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years
I. Kantola, A. Annala, A. Ekstrand, T. Heliö +15 more
20180 citations
Semantic Scholar
PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years
I. Kantola, A. Annala, T. Heliö, A. Hietaharju +14 more
20170 citations
Semantic Scholar
Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases
I. Kantola, A. Annala, T. Heliö, A. Hietaharju +12 more
20160 citations
Semantic Scholar
Factores que afectan la pérdida ósea en la perimenopausia en mujeres sin THR: estudio prospectivo
J. Sirola, H. Kröger, R. Honkanen, Jukka S. Jurvelin +2 more
20030 citations
Semantic Scholar
Effect on bone markers and bone mineral density of three monthly 2 mg intravenous Ibandronate in men with osteoporosis : 2 years of treatment and one year after withdrawal. An open pilot study.
O. Lamy, L. Sandini, I. Pache, S. Fatio +2 more
20030 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Kröger×13
Invite
H. Kröger — researcher profile on SciRah
M. Tuppurainen×11
Invite
M. Tuppurainen — researcher profile on SciRah
R. Honkanen×11
Invite
R. Honkanen — researcher profile on SciRah
J. Sirola×8
Invite
J. Sirola — researcher profile on SciRah

×6

Invite

S. Saarikoski — researcher profile on SciRah

Invite

I. Kantola — researcher profile on SciRah

Invite

A. Annala — researcher profile on SciRah

Invite

T. Kantola — researcher profile on SciRah

Invite

J. Taurio — researcher profile on SciRah

Invite

K. Valtola — researcher profile on SciRah

Invite

S. Walls — researcher profile on SciRah

Invite

E. Alhava — researcher profile on SciRah